Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: An extended study of 77 families

Japanese Journal of Cancer Research

Volumn 91, Issue 2, 2000, Pages 204-212

  Yoshida, Minoru ^a   Ashida, Shingo ^b   Kondo, Keiichi ^a   Kobayashi, Kazuki ^a   Kanno, Hiroshi ^a   Shinohara, Nobuo ^c   Shitara, Nobuyuki ^d   Kishida, Takeshi ^a   Kawakami, Satoshi ^a   Baba, Masaya ^a   Yamamoto, Isao ^b   Hosaka, Masahiko ^a   Shuin, Taro ^b   Yao, Masahiro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Germ line; Mutation; Polymorphism; Tumor suppressor; VHL gene

Indexed keywords

ARTICLE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; GERM LINE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PATHOGENESIS; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; VON HIPPEL LINDAU DISEASE;

EID: 0034062099     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00933.x     Document Type: Article

References (36)

1. Glenn, G. M., Choyke, P. L., Zbar, B. and Linehan, W. M. Von Hippel-Lindau disease. Probl. Uol., 4, 312-330 (1990).
2. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F. M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chen, F., Glenn, G., Choyke, P., Walther, M. M., Weng, Y., Duan, D. R., Dean, M., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Le Paslier, D., Chumakov, I., Cohen, D., Chinault, A. C., Maher, E. R., Linehan, W. M., Zbar, B. and Lerman, M. I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260, 1317-1320 (1993).
3. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F. M., Lubensky, I., Duan, D. R., Florence, C., Pozzatti, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Pomer, S., Brooks, J. D., Isaacs, W. B., Lerman, M. I., Zbar, B. and Linehan, W. M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7, 85-90 (1994).
4. Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., Zbar, B., Lerman, M. I. and Yao, M. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res., 54, 2852-2855 (1994).
5. Kanno, H., Kondo, K., Ito, S., Yamamoto, I., Fujii, S., Torigoe, S., Sakai, N., Hosaka, M., Shuin, T. and Yao, M. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res., 54, 4845-4847 (1994).
6. Gilcrease, M. Z., Schmidt, L., Zbar, B., Truong, L., Rutledge, M. and Wheeler, T. M. Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis. Hum. Pathol., 26, 1341-1346 (1995).
7. Vortmeyer, A. O., Lubensky, I. A., Fogt, F., Linehan, W. M., Khettry, U. and Zhuang, Z. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am. J. Pathol., 151, 951-956 (1997).
8. Zbar, B., Kishida, T., Chen, F., Schmidt, L., Maher, E. R., Richards, F. M., Crossey, P. A., Webster, A. R., Affara, N. A., Ferguson-Smith, M. A., Brauch, H., Glavac, D., Neumann, H. P., Tisherman, S., Mulvihill, J. J., Gross, D. J., Shuin, T., Whaley, J., Seizinger, B., Kley, N., Olschwang, S., Boisson, C., Richard, S., Lips, C. H. M., Linehan, W. M. and Lerman, M. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum. Mutat., 8, 348-357 (1996).
9. Prowse, A. H., Webster, A. R., Richards, F. M., Richard, S., Olschwang, S., Resche, F., Affara, N. A. and Maher, E. R. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Am. J. Hum. Genet., 60, 765-771 (1997).
10. Knudson, A. G. VHL gene mutation and clear-cell renal carcinomas. Cancer J. Sci. Am., 1, 180 (1995).
11. Duan, D. R., Pause, A., Burgess, W. H., Aso, T., Chen, D. Y. T., Garrett, K. P., Conaway, R. C., Conaway, J. W., Linehan, W. M. and Klausner, R. D. Inhibition of transcription elongation by the VHL tumor suppressor. Science, 269, 1402-1406 (1995).
12. Kibel, A., Iliopoulos, O., Decaprio, J. A. and Kaelin, W. G., Jr. Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science, 269, 1444-1446 (1995).
13. Kamura, T., Koepp, D. M., Conrad, M. N., Skowyra, D., Moreland, R. J., Iliopoulos, O., Lane, W. S., Kaelin, W. G., Jr., Elledge, S. J., Conaway, R. C., Harper, J. W. and Conaway, J. W. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science, 284, 657-661 (1999).
14. Tsuchiya, H., Iseda, T. and Hino, O. Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Cancer Res., 56, 2881-2885 (1996).
15. Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Ananth, S. and Sukhatme, V. P. The von Hippel-Lindau tumor suppressor gene product interacts with SpI to repress vascular endothelial growth factor promoter activity. Mol. Cell. Biol., 17, 5629-5639 (1997).
16. Ohh, M., Yauch, R. L., Lonergan, K. M., Whaley, J. M., Stemmer-Rachamimov, A. O., Louis, D. N., Gavin, B. J., Kley, N., Kaelin, W. G., Jr. and Iliopoulos, O. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell, 1, 959-968 (1998).
17. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R. and Ratcliffe, P. J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275 (1999).
18. Cohen, H. T., Zhou, M., Welsh, A. M., Zarghamee, S., Scholz, H., Mukhopadhyay, D., Kishida, T., Zhar, B., Knebelmann, B. and Sukhatme, V. P. An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association. Biochem. Biophys. Res. Commun., 266, 43-50 (1999).
19. Zbar, B., Kaelin, W., Maher, E. and Richard, S. Third International Meeting on von Hippel-Lindau disease. Cancer Res., 59, 2251-2253 (1999).
20. Clinical Research Group for VHL in Japan. Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Hum. Mol. Genet., 4, 2233-2237 (1995).
21. Maniatis, T., Fritsch, E. F. and Sambrook, J. "Molecular Cloning: a Laboratory Manual" (1989). Cold Spring Harbor Press, Cold Spring Harbor, NY.
22. Foster, K., Prowse, A., van den Berg, A., Fleming, S., Hulsbeek, M. M., Crossey, P. A., Richards, F. M., Cairns, P., Affara, N. A., Ferguson-Smith, M. A., Buys, C. H. C. M. and Maher, E. R. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum. Mol. Genet., 3, 2169-2173 (1994).
23. Gao, J., Naglich, J. G., Laidlaw, J., Whaley, J. M., Seizinger, B. R. and Kley, N. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene. Cancer Res., 55, 743-747 (1995).
24. Duan, D. R., Humphrey, J. S., Chen, D. Y., Weng, Y., Sukegawa, J., Lee, S., Gnarra, J. R., Linehan, M. W. and Klausner, R. D. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc. Natl. Acad. Sci. USA, 92, 6459-6463 (1995).
25. Iliopoulos, O., Ohh, M. and Kaelin, W. G., Jr. pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc. Natl. Acad. Sci. USA, 95, 11661-11666 (1998).
26. Schoenfeld, A., Davidowitz, E. J. and Burk, R. D. A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc. Natl. Acad. Sci. USA, 95, 8817-8822 (1998).
27. Stebbins, C. E., Kaelin, W. G., Jr. and Pavletich, N. P. Structure of the VHL-elongin C-elongin B complex: implications for VHL tumor suppressor function. Science, 284, 455-461 (1999).
28. Okuda, H., Hirai, S., Takaki, Y., Kamata, M., Baba, M., Sakai, N., Kishida, T., Yao, M., Ohno, S. and Shuin, T. Direct interaction of the β-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes. Biochem. Biophys. Res. Commun., 263, 491-497 (1999).
29. Kishida, T., Stackhouse, T. M., Chen, F., Lerman, M. I., and Zbar, B. Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping the binding domains and the effect of missense mutations. Cancer Res., 55, 4544-4548 (1995).
30. Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway, J. W., and Kaelin, W. G., Jr. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol. Cell. Biol., 18, 732-741 (1998).
31. Kanno, H., Shuin, T., Kondo, K., Ito, S., Hosaka, M., Torigoe, S., Fujii, S., Tanaka, Y., Yamamoto, I., Kim, I. and Yao, M. Molecular genetic diagnosis of von Hippel-Lindau disease: analysis of five Japanese families. Jpn. J. Cancer Res., 87, 423-428 (1996).
32. Stolle, C., Glenn, G., Zbar, B., Humphrey, J. S., Choyke, P., Walther, M., Pack, S., Hurley, K., Andrey, C., Klausner, R. and Linehan, W. M. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum. Mutat., 12, 417-423 (1998).
33. Suzuki, D. T., Griffiths, A. F. J., Miller, J. H. and Lewontin, R. C. "An Introduction to Genetic Analysis," 3rd Ed., pp.333-353 (1986). W. H. Freeman, New York.
34. Sommer, S. S. Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene. FASEB J., 6, 2767-2774 (1992).
35. Kinzler, K. W. and Vogelstein, V. Lessons from hereditary colorectal cancer. Cell, 87, 159-170 (1996).
36. Eng, C., Crossey, P. A., Mulligan, L. M., Healey, C. S., Houghton, C., Prowse, A., Chew, S. L., Dahia, P. L., O'Riordan, J. L., Toledo, S. P., Smith, D. P., Maher, E. R. and Ponder, B. A. J. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J. Med. Genet., 32, 934-937 (1995).